Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: Ipsen Limited, 190 Bath Road, Slough SL1 3XE, United Kingdom
Decapeptyl SR 22.5 mg powder and solvent for suspension for injection.
| Pharmaceutical Form |
|---|
|
Powder and solvent for suspension for injection, sustained release formulation. Powder: White to off-white powder. Solvent: Clear solution. |
Triptorelin (I.N.N) 28 mg as triptorelin pamoate.
The vial contains an overage to ensure that a dose of 22.5 mg is administered to the patient.
For a full list of excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Triptorelin |
Triptorelin is a decapeptide analogue of GnRH which initially stimulates release of pituitary gonadotropins. |
| List of Excipients |
|---|
|
Powder: Poly (d,l-lactide-co-glycolide) Solvent: Water for injections |
6 mL septum vial with bromobutyl stopper and aluminium flip-off cap.
Ampoule containing 2 mL of sterile solvent for suspension.
Box of: 1 vial, 1 ampoule and 1 blister containing 1 injection syringe and 2 injection needles.
Ipsen Limited, 190 Bath Road, Slough SL1 3XE, United Kingdom
PL 34926/0013
14 Sept 2010
| Drug | Countries | |
|---|---|---|
| DECAPEPTYL | Austria, Australia, Ecuador, Spain, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, Poland, Singapore, Tunisia, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
